Clinical applicability and cost-effectiveness of DIABSCORE in screening for type 2 diabetes in primary care

Highlights • DIABSCORE was developed and validated an risk score for screening of type 2 diabetes in a general population cohort. • DIABSCORE showed a high sensitivity to detect cases of type 2 diabetes and a high negative predictive value to rule out the presence of diabetes. • DIABSCORE has showed...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes research and clinical practice 2017-08, Vol.130, p.15-23
Main Authors: Rodríguez-Pérez, María Cristo, Orozco-Beltrán, Domingo, Gil-Guillén, Vicente, Domínguez-Coello, Santiago, Almeida-González, Delia, Brito-Díaz, Buenaventura, Marcelino-Rodríguez, Itahisa, Carratalá-Munuera, María Concepción, Gómez-Moreno, Nieves, Navarro-Perez, Jorge, Brotons-Munto, Francisco, Pertusa-Martinez, Salvador, León, Antonio Cabrera de
Format: Article
Language:English
Subjects:
Adult
Blood Glucose
Clinic epidemiology
Cost effectiveness
Cost-Benefit Analysis
Cross-Sectional Studies
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - diagnosis
Diabetes Mellitus, Type 2 - epidemiology
Endocrinology & Metabolism
Female
Humans
Mass Screening - economics
Mass Screening - methods
Middle Aged
Odds Ratio
Pregnancy
Prevalence
Primary Health Care
ROC Curve
Screening
Spain - epidemiology
Type 2 diabetes
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • DIABSCORE was developed and validated an risk score for screening of type 2 diabetes in a general population cohort. • DIABSCORE showed a high sensitivity to detect cases of type 2 diabetes and a high negative predictive value to rule out the presence of diabetes. • DIABSCORE has showed to be a valid method for opportunistic screening of type 2 diabetes in primary care that is applicable in different populations. • DIABSCORE does not require invasive methods and competes advantageously with blood glucose and HbA1c in terms of patient and professional satisfaction. • DIABSCORE is a cost-effective screening method for type 2 diabetes in primary care compared to the use of blood glucose or HbA1c.
ISSN:0168-8227
1872-8227
DOI:10.1016/j.diabres.2017.05.009